Plain-English translation of NCT07788833 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing RSB11-HI, a postbiotic supplement made from beneficial bacteria, to see if it can help healthy adults manage their weight and support metabolic health. A postbiotic is a substance produced by good bacteria that may have health benefits. Researchers will compare the medication to a placebo (a dummy pill) over 8 weeks to understand whether it actually works and is safe.
Many people struggle with weight management and metabolic wellness, and researchers want to explore new natural approaches that might help. This medication is being tested because early research suggests it could support these health goals, but it needs rigorous testing to confirm whether it truly makes a difference in real people.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll take either the postbiotic supplement or a placebo pill once daily for 8 weeks — neither you nor the researchers will know which one you're receiving until the study ends. You'll complete regular check-ins and assessments online using your computer or phone, answer questions about your weight, energy, digestion, and overall quality of life, and maintain your normal diet and exercise routine. The study is designed to be convenient, with most activities done from home.
AI-generated summary from trial data · Aug 31, 2026 · Not medical advice
United States